Cystic Fibrosis News

Image of an orange button with white text that says "read more."

Cystic fibrosis news shared on CFRI’s social media pages related to CF research, education, advocacy, patient wellness support and more!

OCTOBER, 2021

TRIKAFTA NOW COVERED IN 2 MORE CANADIAN PROVINCES

ANTIBIOTIC-RESISTANT BACTERIA IN FISH TREATED BY ADDING PHAGE THERAPY

ULTRASOUNDS MAY HELP DIAGNOSE PANCREATIC INSUFFICIENCY IN CHILDREN WITH CF

TWO STUDIES PROVIDE EVIDENCE THAT MASKS PROTECT CHILDREN FROM CORONAVIRUS – Study 1Study 2

COVID-19 VACCINES DO NOT INCREASE RISK OF MISCARRIAGE OR BIRTH DEFECTS

NIH DIRECTOR DR. FRANCIS COLLINS STEPPING DOWN

CF PATIENTS WITH COVID-19 AT HIGHER RISK OF POOR OUTCOMES

PHASE 1 STUDY OF KB407 TO BE LAUNCHED IN AUSTRALIA

CDC RELEASES GUIDANCE FOR UPCOMING HOLIDAY SEASON

FDA ISSUES BEST PRACTICES FOR COMMUNICATING CYBERSECURITY VULNERABILITIES TO PATIENTS

INHALATION POWDER FOR MUCUS CLEARANCE AVAILABLE FOR THOSE WHO PASS THE BRONCHITOL TOLERANCE TEST

PHASE 1/2 TRIAL OF AEROSOL GENE THERAPY FOR CF MAY START SOON

GUT MICROBIOME SLOW TO DEVELOP IN CF INFANTS

EPICORE LAUNCHES WEARABLE PATCH TO CONDUCT SWEAT COLLECTION TESTS

PFIZER, BIONTECH ASK FDA TO AUTHORIZE CORONAVIRUS VACCINE FOR CHILDREN 5 TO 11 YEARS OLD

MERCK APPLIES FOR FDA EMERGENCY AUTHORIZATION FOR ANTIVIRAL PILL TO TREAT COVID-19

SEPTEMBER, 2021

MS1819 PLUS PERT IMPROVED FAT ABSORPTION IN SEVERE EPI

CONTRIBUTE YOUR PERSONAL EXPERIENCES WITH TRIKAFTA TO CF RESEARCH

CENTERS FOR MEDICARE AND MEDICAID SERVICES ISSUE NEW CODE FOR ENCALA

PFIZER-BIONTECH’S COVID VACCINE RECEIVES FULL FDA APPROVAL

MONOCLONAL ANTIBODY TREATMENT HIGHLY EFFECTIVE AGAINST MILD TO MODERATE COVID-19

WORLD HEALTH ORGANZIATION CALLS FOR TWO-MONTH VACCINE BOOSTER MORATORIUM

LUNG CLEARANCE INDEX USEFUL IN ASSESSING LUNG FUNCTION

KALYDECO APPROVED IN CANADA TO TREAT INFANTS 4 MONTHS AND OLDER

FDA UNDER GROWING PRESSURE TO AUTHORIZE COVID-19 VACCINES FOR CHILDREN YOUNGER THAN 12

EXPERTS WORRY CHILDREN OF COLOR FACE GREATEST RISK AS COVID-19 INFECTS MORE CHILDREN IN US

PRIOR COVID-19 INFECTION MAY NOT GUARANTEE HIGH LEVEL OF ANTIBODIES OR STRONG RESPONSE AFTER JUST ONE COVID-19 VACCINE DOSE

CHOOSING AN AIR PURIFIER TO ADDRESS COVID AND WILDFIRE SMOKE

POLYPHOR AND ENBIOTIX TO MERGE, PLAN TRIALS IN 2 LUNG INFECTION THERAPIES

MINORITIES WITH CF MORE LIKELY TO EXPERIENCE LOWER LUNG FUNCTION THAN CAUCASIAN PATIENTS

PEDIATRIC HOSPITALIZATIONS DUE TO COVID-19 SPIKED DURING SUMMER MONTHS AMID DELTA VARIANT SPREAD

WHO MONITORING NEW CORONAVIRUS “VARIANT OF INTEREST.”

NORTH CAROLINA CO-PAY ACCUMULATOR BAN PASSES AND AWAITS GOVERNOR’S SIGNATURE

HHS PROPOSES TO WITHDRAW DRUG PRICING RULE

AVERAGE COVID-19 HOSPITALIZATION COSTS MEDICARE 150 TIMES MORE THAN VACCINATING ONE INDIVIDUAL, ANALYSIS SHOWS

BIDEN ADMINISTRATION ANNOUNCES COVID-19 VACCINE MANDATE FOR FEDERAL WORKERS, CONTRACTORS, PRIVATE COMPANIES WITH MORE THAN 100 WORKERS

MORE AMERICANS HAD COVID-19 AT THE END OF 2020 THAN PREVIOUSLY ESTIMATED

ELX-02, POTENTIAL CF NONSENSE MUTATION THERAPY, ON FDA FAST TRACK

SFPQ PROTEIN HELPS TO RESTORE CFTR IN CELLS WITH COMMON MUTATION

STUDY SHOWS VALUE OF BIOFILM COMPONENT IN P. AERUGINOSARESISTANCE

FDA SAYS IT HOPES TO MOVE QUICKLY ON AUTHORIZING COVID-19 VACCINES FOR YOUNGER CHILDREN

THE FIGHT FOR A LIFE-CHANGING DRUG: GETTING TRIKAFTA APPROVED IN ALBERTA

PANDEMIC PLACES SOCIOECONOMIC HARDSHIPS ON CF PATIENTS

PUBLIC REIMBURSEMENT OF TRIKAFTA ONE STEP CLOSER IN CANADA

AIRPHYSIO LUNG CLEARANCE DEVICE NOW SOLD ONLINE FOR U.S. PATIENTS

JOHNSON & JOHNSON’S COVID-19 VACCINE IS MORE EFFECTIVE WHEN GIVEN AS A TWO-DOSE REGIMEN

ONE IN THREE PEOPLE WHO SURVIVED COVID-19 REPORT SUFFERING FROM LONG COVID

EMILY’S ENTOURAGE HOSTED FDA LISTENING SESSION FOR THE FINAL 10% OF PEOPLE WITH CYSTIC FIBROSIS

FTC ISSUES STATEMENT CONFIRMING CONNECTED DEVICES MUST COMPLY WITH DATA BREACH RULE

 

AUGUST, 2021

SECRETORY CELLS DOMINATE AIRWAY CFTR EXPRESSION AND FUNCTION IN HUMAN AIRWAY SUPERFICIAL EPITHELIA

SEMGLEE APPROVED AS FIRST INTERCHANGEABLE BIOSIMILAR INSULIN PRODUCT

INDIVIDUALS WITH CYSTIC FIBROSIS DO NOT APPEAR TO HAVE HIGHER RISK FOR SARS-COV-2 INFECTION

NUTRITIONAL STATUS OF CHILDREN WITH CF LINKED TO TEENAGE-ONSET DIABETES

SANOFI TO ACQURE TRANSLATE BIO

CDC SUGGESTS VACCINATED INDIVIDUALS INFECTED WITH DELTA CORONAVIRUS VARIANT CARRY HIGH VIRAL LOADS

CDC CALLS FOR FULLY VACCINATED INDIVIDUALS TO BE TESTED FOR COVID-19 FOLLOWING EXPOSURE EVEN IF ASYMPTOMATIC

IT IS TIME TO LET GO OF THE QALY”S LEGACY OF DISCRIMINATION

LOW BONE DENSITY IN CF ADULTS MAY BE TIED TO INFLAMMATION MARKER

CFTR PROTEIN DYNAMIC, CHANGING SHAPES IN WAYS AFFECTING DISEASE

CHRONIC SINUS INFLAMMATION MAY ALTER BRAIN ACTIVITY

BIONTECH SAYS BOOSTER SHOT A BETTER STRATEGY THAN TAILORING VACCINE TO NEW VARIANT

US TOPS 100,000 DAILY COVID-19 CASES FOR FIRST TIME SINCE WINTER

STUDY SHOWS J&J COVID-19 VACCINE 96.2% EFFECTIVE AGAINST SEVERE ILLNESS AND DEATH

HHS PROPOSES TO WITHDRAW DRUG PRICING RULE

INSURERS OPPOSE HHS PROPOSAL TO EXTEND ACA ANNUAL ENROLLMENT PERIOD

COLLEGE STUDENT WITH CF APPOINTED TO NEW RARE DISEASE ADVISORY COUNCIL IN OHIO

ATS/AMERICAN LUNG ASSOC. JOINT STATEMENT OPPOSING PHILLIP MORRIS INT’L BID TO AQUIRE VECTURA

PATIENT GROUPS AMENDMENTS TO CALIFORNIA AB 1130

PRIME EDITING, ADVANCE ON CRISPR, SHOWS POTENTIAL ON CFTR MUTATIONS

NEW METHOD TO PRODUCE HIGH-YIELD, HIGH-PURITY RNA MAY AID CF TREATMENT

LUNG TRANSPLANT BIOREPOSITORY, REGISTRY TARGETS PATIENT OUTCOMES

BOOSTER DOSE OF COVID VACCINE NOW RECOMMENDED FOR THE IMMUNO-COMPROMISED

MULTIPLE SAFETY MEASURES CAN PROVIDE STRONG PROTECTION AGAINST COVID-19 AMID RETURN TO IN-PERSON LEARNING

CALIFORNIA SENATE BILL 247 TO BE HEARD IN ASSEMBLY APPROPRIATIONS COMMITTEE AUGUST 19

LETTER IN OPPOSITION TO PMI ACQUISITION OF VECTURA

INSURERS OPPOSE HHS PROPOSAL TO EXTEND ACA ANNUAL ENROLLMENT PERIOD

BABIES AND TODDLERS SPREAD VIRUS IN HOMES MORE EASILY THAN TEENS, STUDY FINDS

RACIAL, SOCIAL DISPARITIES INFLUENCE ASTHMA-RELATED HOSPITAL READMISSIONS

 

JULY, 2021

MORNINGS ARE TOUGH WITH CF

THE WHO SAYS FULLY VACCINATED PEOPLE SHOULD CONTINUE TO WEAR FACE MASKS IN PUBLIC SETTINGS

LOW LEVELS OF VIP HORMONE MAY CONTRIBUTE TO EARLY CF-RELATED DIABETES

SEVERE COVID-19 MORE LIKELY IN CF CARRIERS THAN PATIENTS

JOINT DISEASE LINKED TO P. AERUGINOSA INFECTION, FEMALE SEX

SOME MINORS SEEK TO GET COVID-19 VACCINE AGAINST PARENTS’ WISHES

STUDY SUGGESTS MODERNA COVID-19 VACCINE EFFECTIVE AGAINST DELTA VARIANT

DELTA VARIANT IS MAKING OFFICIALS RETHINK MASK GUIDELINES

WHO ESTIMATES YEARLY COVID-19 BOOSTERS MAY BE NEEDED FOR MOST VULNERABLE

SUPREME COURT REJECTS LATEST CHALLENGE TO AFFORDABLE CARE ACT

TENSIN 1 GENE VARIANTS MAY AFFECT NUTRITION IN CF PATIENTS

ARROWHEAD PAUSES ARO-ENAC STUDY AMID SAFETY CONCERNS

11% OF PEOPLE IN THE U.S. HAVE MISSED THEIR SECOND COVID-19 VACCINE DOSE

US HEALTH OFFICIALS NOT YET RECOMMENDING THIRD DOSE OF COVID-19 VACCINE FOR PEOPLE WITH IMMUNE CONDITIONS

AIRWAY INFLAMMATION AFFECTS PH, RESPONSE TO CFTR THERAPIES

DATA FROM PHASE 2 TRIALS OF ELX-02 EXPECTED THIS YEAR

UNDERVACCINATED CLUSTERS MAY BECOME BREEDING GROUNDS FOR MORE FATAL CORONAVIRUS VARIANTS

PFIZER-BIONTECH TO SEEK FDA AUTHORIZATION FOR THIRD DOSE OF COVID-19 VACCINE

FDA CLEARS TACROLIMUS TO PREVENT LUNG TRANSPLANT REJECTION

HORMONE FLUCTUATIONS TIED TO CHANGES IN LUNG FUNCTION IN WOMEN WITH CYSTIC FIBROSIS

STUDY DESCRIBES NEW COMPOUND FOR NONSENSE MUTATIONS

FDA GRANTS PRIORITY REVIEW TO PFIZER-BIONTECH’S APPLICATION FOR FULL APPROVAL OF COVID-19 VACCINE

WILDFIRE SMOKE MAY INCREASE RISK OF COVID-19

 

JUNE, 2021

RACE, INCOME LIMIT CF LUNG TRANSPLANT ACCESS IN US MORE THAN CANADA

ELOXX ANNOUNCES FUNDING AWARD FROM CFF FOR DEVELOPMENT OF RIBOSOME MODULATING AGENTS (RMAs)

TRIKAFTA RECEIVES FDA APPROVAL FOR USE IN CHILDREN WITH CYSTIC FIBROSIS, AGE 6-11 WITH CERTAIN MUTATIONS

BENEFITS OF TRIPLE-COMBO TRIKAFTA FOR CF MOSTLY DUE TO ELEXACAFTOR

NEW CELL RESEARCH MODEL SHOWS PROMISE AGAINST P. AERUGINOSA

DR. FAUCI URGES VACCINATION AGAINST COVID-19 VARIANT SPREADING TO US FROM INDIA

UNITEDHEALTHCARE DELAYS PLANS TO DENY SOME EMERGENCY VISITS AMID OUTCRY

ANTIBODY-LADEN NASAL SPRAY COULD PROVIDE COVID PROTECTION

PHILIPS RECALLS MILLIONS OF VENTILATORS, SLEEP APNEA DEVICES OVER POTENTIAL HEALTH RISKS

RNA-BASED THERAPIES SHOW PROMISE IN EARLY STUDIES

MOLECULES IN PATIENTS’ BREATH MAY INDICATE P. AERUGINOSA INFECTION

STUDY SHOWS THAT COVID-19 BOOSTER SHOT MAY HELP PROTECT SOME TRANSPLANT PATIENTS

CASES OF COVID-19 DELTA VARIANT ARE RISING IN THE US

TRIAL RESULTS SHOW NOVAVAX COVID-19 VACCINE CANDIDATE 90.4% EFFECTIVE

VACCINATION RATES AMONG LATINX AND AFRICAN AMERICAN COMMUNITIES LAG BEHIND

MODERNA APPLIES FOR FDA AUTHORIZATION FOR USE OF ITS COVID-19 VACCINE IN ADOLESCENTS

U.S. TO BUY 500M DOSES OF PFIZER-BIONTECH VACCINE FOR OTHER COUNTRIES

HEALTH CANADA APPROVES TRIKAFTA FOR CF PATIENTS AGES 12 AND UP

NEW STRATEGY CORRECTS CF SPLICING DEFECTS IN LAB MODELS

YOUNGER ADULTS’ COVID-19 VACCINATION RATES SLOWER THAN OLDER ADULTS

MANY LOW-INCOME IMMIGRANTS RESORT TO UNPROVEN COVID-19 TREATMENTS

SUPREME COURT REJECTS LATEST CHALLENGE TO AFFORDABLE CARE ACT

DELTA COVID-19 VARIANT SPREADING IN UNVACCINATED US COUNTIES, ANALYSIS FINDS

 

MAY, 2021

NEW CRISPR TECHNOLOGY OFFERS CONTROL OF EPIGENETIC INHERITANCE

SOCIAL DISTANCING INSIDE CAN PROVIDE A FALSE SENSE OF SECURITY

MANY WHO TEST POSITIVE FOR COVID-19 BUT DO NOT REQUIRE HOSPITAL CARE SEEK MEDICAL CARE IN FOLLOWING MONTHS

KB407 GENE THERAPY FOUND SAFE IN ANIMALS, IN-HUMAN TRIAL EXPECTED LATER THIS YEAR

CDC SAYS FULLY VACCINATED AMERICANS CAN NOW GO OUTSIDE WITHOUT A MASK

CPAP THERAPY MAY AFFECT BMI IN ADULTS WITH OSA, STUDY INDICATES

MANY PEOPLE STILL PREFER CONVENIENCE OF JOHNSON AND JOHNSON ONE-DOSE COVID-19 VACCINE

FDA PROMISES TO ISSUE NEW RULES WITHIN A YEAR BANNING MENTHOL IN TOBACCO PRODUCTS

REACHING ‘HERD IMMUNITY’ IS UNLIKELY IN THE U.S

CHILDREN ACCOUNT FOR 22.4% OF NEW #COVID19 CASES IN THE US

WORLD ORPHAN DRUG CONGRESS: RARE DISEASE TRIALS AND PATIENT REGISTRIES

FDA TO AUTHORIZE PFIZER-BIONTECH COVID-19 VACCINE FOR CHILDREN AGES 12 – 15

PDE4 INHIBITORS MAY HELP TREAT CF, DRY MOUTH

EU OPENS KAFTRIO TO ALL CF PATIENTS 12 AND UP WITH F508DEL MUTATION

ELOXX ADDS KALYDECO TO ONGOING PHASE 2 TRIAL OF ELX-02

OP-ED: ANTIBIOTIC RESISTANCE, CHRONIC DISEASE AND COVID-19 – A TRIPLE THREAT

CDC UPDATES GUIDELINES ON CORONAVIRUS, EMPHASIZING AIRBORNE TRANSMISSION

TOBRAMYCIN GIVEN IN NANOPARTICLES SHOWS POTENTIAL TO TREAT P. AERUGINOSA

MS1819 PLUS PERT IMPROVES DIGESTION IN PEOPLE WITH SEVERE EPI

SPLISENSE RAISES $28.5 MILLION TO ADVANCE RESTORATIVE CF THERAPY

SURVEY FINDS THAT MANY UNVACCINATED LATINX ADULTS IN THE US WANT COVID-19 SHOT

ANTIBODY COCKTAIL REDUCES HOSPITALIZATION, DEATH AMONG HIGH-RISK, NON-HOSPITALIZED PATIENTS WITH COVID-19

CDC SAYS FULLY VACCINATED CAN GO WITHOUT MASKS OR PHYSICAL DISTANCING IN MOST CIRCUMSTANCES

CDC SAYS MOST PEOPLE WHO ARE FULLY VACCINATED AGAINST COVID-19 AND HAVE NO SYMPTOMS DO NOT NEED TO BE TESTED FOR THE VIRUS, EVEN IF EXPOSED

SPIROMETRY MEASUREMENTS TAKEN AT HOME DON’T MATCH WITH THOSE OBTAINED IN CLINIC

EU, UK CONSIDER EXPANDING KAFTRIO TO CHILDREN AGES 6 AND OLDER

TWO STUDIES INDICATE COVID-19 MITIGATION MEASURES CAN HELP SCHOOLS STAY OPEN AND KEEP STUDENTS SAFE

US CHILDREN WITH CF HAVE BETTER LUNG FUNCTION THAN UK CHILDREN

HEALTH DISPARITY OBVIOUS IN AVAILABLE TREATMENTS FOR SICKLE CELL COMMUNITY

 

APRIL, 2021

SWEAT-MEASURING STICKER MAY AID CF DIAGNOSIS IN CHILDREN

LEAVING MIDDLE SEATS ON AIRPLANES VACANT MAY REDUCE RISK OF CORONAVIRUS EXPOSURE

RISK OF BRAIN BLOOD CLOTS IS HIGHER FROM COVID-19 INFECTION THAN FROM COVID-19 VACCINES

EXPERTS CONCERNED ABOUT IMPACT OF J&J CORONAVIRUS VACCINE PAUSE

FREE ONLINE CLASSES FOR THE CF COMMUNITY AT STROLO UNIVERSITY

CFRI JOINS 80 NATIONAL PATIENT GROUPS IN AN OPEN LETTER CALLING ON LAWMAKERS TO REJECT HEALTH POLICIES THAT DISCRIMINATE

OPTION 2 TRIAL TESTING MS1819 FOR EPI POSTS ‘MIXED’ TOPLINE RESULTS

RESPINOVA’S PULSEHALER DEVICE RECEIVES FDA APPROVAL

PHASE 2 TRIAL ADVANCING: BX004, PHAGE THERAPY FOR BACTERIAL INFECTIONS

RACIAL BIAS IN PULSE OXIMETRY MEASUREMENTS

APRIL 24TH IS TAKE BACK DAY – AN IMPORTANT REMINDER TO SAFELY DISPOSE OF UNUSED MEDICATION

CDC: HALF OF ALL US ADULTS HAVE RECEIVED AT LEAST ONE COVID-19 VACCINE DOSE

 

MARCH, 2021

 

FEBRUARY, 2021

OP-ED: SB 5020 INCLUDES GROUP KNOWN FOR DISCRIMINATORY PRACTICES

ASTRAZENECA VACCINE APPEARS TO SUBSTANTIALLY REDUCE TRANSMISSION OF THE CORONAVIRUS

FDA TO REVIEW TRIKAFTA FOR PATIENTS AS YOUNG AS SIX YEARS

KINNEAR PHARMACEUTICALS TO RECEIVE UP TO $3M TO FOR DEVELOPMENT OF ANTI-INFECTIVE FROM CF FOUNDATION

TRANSMISSION AND ANTIBIOTIC RESISTANCE OF ACHROMOBACHTER BACTERIA IN CYSTIC FIBROSIS

 

JANUARY, 2021

AzurRx STARTS DOSING FIRST CF PATIENTS IN STUDY OF LIPASE ENZYME MS1819

MINORITIES IN US OFTEN INELIGIBLE FOR CFTR MODULATORS DUE TO POORLY STUDIED MUTATIONS

UPDATE: WASHINGTON STATE SENATE HEALTH AND LONG TERM CARE COMMITTEE HEARS TESTIMONY ON SB 5020: “Rx DRUG PRICE INCREASES”